Apollo Care
FDA 503B outsourcing facility
Columbia, Missouri
Key Takeaways
- FDA-registered 503B outsourcing facility since 2017
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: March 28, 2025
- FDA action: Warning Letter Issued 2/2/2026
- 23 FDA drug recalls on record (2018 to 2025)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- September 14, 2017
- Most recent registration
- December 24, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- March 28, 2025
The FDA last inspected Apollo Care on March 28, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. FDA action on record: Warning Letter Issued 2/2/2026.
FDA recall history
Apollo Care has 23 FDA drug recalls on record between 2018 and 2025, based on the FDA enforcement database. Breakdown: 23 Class II.
Recall reasons on record include lack of assurance of sterility; lack of assurance of sterility: suspected microbial growth present on external label; crystallization: product appears to be turbid; stability data does not support expiry: 90-day beyond use date (bud) for the affected.
| Date | Class | Product | Reason |
|---|---|---|---|
| April 2025 | Class II | FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, | Lack of Assurance of Sterility |
| May 2023 | Class II | FentaNYL 500 mcg (2mcg/mL) and Ropivacaine HCL 250 mg (0.1%) added to 250 mL 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 | Lack of Assurance of Sterility |
| May 2023 | Class II | Ketamine Injection, 50 mg per 5 mL (10 mg/mL), Single-Use Syringe, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202 | Lack of Assurance of Sterility |
| May 2023 | Class II | VANComycin 1.5g added to 250 mL of 0.9% Sodium Chloride Injection, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202 | Lack of Assurance of Sterility |
| May 2023 | Class II | Norepinephrine 4 mg added to 250 mL of 5% Dextrose Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC | Lack of Assurance of Sterility |
Showing the 5 most recent of 23 recall events.
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
What this facility compounds
Apollo Care reports compounding 10 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Semaglutide, Tirzepatide.
- Fentanyl Citrate
- Ketamine Hydrochloride
- Norepinephrine
- Phenylephrine Hydrochloride
- Ropivacaine Hydrochloride; Fentanyl Citrate
- Semaglutide
- Semaglutide; Cyanocobalamin
- Succinylcholine Chloride
- Tirzepatide; Pyridoxine Hydrochloride
- Vancomycin Hydrochloride
Location
3801 Mojave Ct Ste 101, N/A, Columbia, MO 65202-4042
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Jarred Dudding, 573-441-8900. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Apollo Care with the Missouri Board of Pharmacy.
503B facilities in Missouri
Missouri has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Missouri.
Frequently asked questions
Is Apollo Care registered with the FDA?
Yes. Apollo Care is a registered 503B outsourcing facility, first registered with the FDA on September 14, 2017 and most recently registered on December 24, 2025.
Has Apollo Care been inspected by the FDA?
The FDA last inspected Apollo Care on March 28, 2025. A Form FDA 483 was issued. FDA action on record: Warning Letter Issued 2/2/2026.
Has Apollo Care had any FDA drug recalls?
Apollo Care has 23 FDA drug recalls on record (2018 to 2025) in the FDA enforcement database.
What does Apollo Care compound?
Apollo Care reports compounding 10 active ingredients to the FDA, including Semaglutide, Tirzepatide.
Where is Apollo Care located?
Apollo Care is located in Columbia, Missouri (3801 Mojave Ct Ste 101).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Apollo Care. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.